Functional Inspiratory Muscle Training in Patients Diagnosed With Hypertension
NCT ID: NCT06343246
Last Updated: 2024-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2023-05-01
2024-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inspiratory Muscle Training in Pulmonary Hypertension
NCT03385733
Inspiratory Muscle Training in Mechanically Ventilated Patients in Intensive Care Unit
NCT06609564
Effects of Inspiratory Muscle Training in Patients With Pulmonary Hypertension
NCT04152187
Exercise Training and Respiratory Muscle Training in Individuals With Metabolic Syndrome(METS)
NCT05413434
Inspiratory Muscle Training in Heart Failure
NCT04839211
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Functional IMT Group (n:15): will receive functional inspiratory muscle training (exercise + 50% of MIP) IMT Group I (n:15): will recieve inspiratory muscle training (50% of MIP ) Control group (n:15): will recieve breathing exercises training
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Functional IMT Group
Functional IMT Group (n:15) : will recieve functional inspiratory muscle training (exercise + 50% of MIP)
Inspiratory muscle training with device
: A randomized, controlled three-arm study. Forty-five patients with HT randomized three group: Group 1 will receive IMT (7 days/8 weeks) with function and POWERbreathe® Classic LR device, group 2 will reviece only IMT with 50 % maximal inspiratory pressure (MIP), n: 15) and control group will recieve breathing exercises(7 days/8 weeks).
IMT Group
IMT Group I (n:15): will recieve inspiratory muscle training (50% of MIP )
Inspiratory muscle training with device
: A randomized, controlled three-arm study. Forty-five patients with HT randomized three group: Group 1 will receive IMT (7 days/8 weeks) with function and POWERbreathe® Classic LR device, group 2 will reviece only IMT with 50 % maximal inspiratory pressure (MIP), n: 15) and control group will recieve breathing exercises(7 days/8 weeks).
Control group
Control group (n:15): will recieve breathing exercises training
Inspiratory muscle training with device
: A randomized, controlled three-arm study. Forty-five patients with HT randomized three group: Group 1 will receive IMT (7 days/8 weeks) with function and POWERbreathe® Classic LR device, group 2 will reviece only IMT with 50 % maximal inspiratory pressure (MIP), n: 15) and control group will recieve breathing exercises(7 days/8 weeks).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inspiratory muscle training with device
: A randomized, controlled three-arm study. Forty-five patients with HT randomized three group: Group 1 will receive IMT (7 days/8 weeks) with function and POWERbreathe® Classic LR device, group 2 will reviece only IMT with 50 % maximal inspiratory pressure (MIP), n: 15) and control group will recieve breathing exercises(7 days/8 weeks).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. It will include both male and female subjects aged ≥18 and \<80 years with a previous diagnosis of essential hypertension.
3. Subjects receiving no pharmacological treatment or receiving only thiazide diuretics
4. Those with a body mass index \<30 kg/m2 Those who engage in \<150 minutes of moderate or intense physical activity per week, according to the 5th International Physical Activity Survey
Exclusion Criteria
2. Severe dyspnea; diabetes; orthopedic, musculoskeletal, or fitness limitations;
3. Major physiological crises;
4. A current or past history of deep venous thrombosis; History of myocardial infarction or stroke within the 5th year or 6 months ago;
6\. Congestive heart therapy; 7. Unstable angina; 8. or lung disease of any etiology (including asthma and chronic obstructive pulmonary disease); 9. Active smokers 10. Patients under 18 years of age 11. Pregnant women 12. Those with Active Infection 13. Those with Known Malignancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mustafa Kemal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Irem Hüzmeli
Assistant Prof. PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
İrem Hüzmeli
Role: PRINCIPAL_INVESTIGATOR
Mustafa Kemal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hatay Mustafa Kemal University
Hatay, Antakya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Huzmeli I, Katayifci N, Abay B, Akkus O, Ozer AY. The effectiveness of functional inspiratory muscle training on exercise capacity and peripheral muscle strength in patients with essential hypertension: a three-arm randomized controlled trial. BMC Sports Sci Med Rehabil. 2025 Feb 28;17(1):29. doi: 10.1186/s13102-025-01082-w.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MustafaKemalU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.